Calidi Biotherapeutics Inc (CLDI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Operating Expenses | 5,414 | 15,297 | 6,986 | 362 | 529 |
| Operating Income | -5,414 | -15,252 | -6,986 | -362 | -529 |
| Interest Expense | 217 | 129 | 29 | 0 | 0 |
| Other Income | -827 | -10,305 | 1,661 | 4,523 | 1,991 |
| Pre-tax Income | -6,458 | -25,685 | -5,354 | 4,161 | 1,462 |
| Income Tax | 4 | 10 | 1 | N/A | N/A |
| Net Income Continuous | -6,462 | -25,695 | -5,355 | 4,161 | 1,462 |
| Net Income | $-6,462 | $-25,695 | $-5,355 | $4,161 | $1,462 |
| EPS Basic Total Ops | -90.04 | -306.12 | -75.63 | 16.81 | 6.00 |
| EPS Basic Continuous Ops | -89.63 | -401.26 | -75.05 | 86.88 | 30.53 |
| EPS Diluted Total Ops | -90.04 | -306.12 | -75.63 | 16.81 | 6.00 |
| EPS Diluted Continuous Ops | -89.63 | -401.26 | -75.05 | 86.88 | 30.53 |
| EBITDA(a) | $-5,030 | $-15,096 | $-6,986 | $-362 | $-529 |